Literature DB >> 18432753

Animal models for the analysis of immune responses to leishmaniasis.

D L Sacks1, P C Melby.   

Abstract

This unit focuses on the murine model of cutaneous leishmaniasis and models of visceral leishmaniasis in mice and hamsters. Each basic protocol describes the methods used to inoculate parasites and to evaluate infections with regard to lesion progression and visceralization, and quantification of parasite load. Five support protocols are provided; two for the growth and isolation of metacyclic promastigotes from in vitro culture, one for isolation of tissue amastigotes from infected animals, one for cryopreservation of parasites, and one for the preparation of blood agar plates for quantitation of parasite numbers in infected tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18432753      PMCID: PMC4363783          DOI: 10.1002/0471142735.im1902s28

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  62 in total

1.  Leishmania major and L. donovani: a method for rapid purification of amastigotes.

Authors:  T A Glaser; S J Wells; T W Spithill; J M Pettitt; D C Humphris; A J Mukkada
Journal:  Exp Parasitol       Date:  1990-10       Impact factor: 2.011

2.  Extracellular cultivation and morphological characterization of amastigote-like forms of Leishmania panamensis and L. braziliensis.

Authors:  S Eperon; D McMahon-Pratt
Journal:  J Protozool       Date:  1989 Sep-Oct

3.  Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.

Authors:  N Courret; E Prina; E Mougneau; E M Saraiva; D L Sacks; N Glaichenhaus; J C Antoine
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

4.  [A comparative study of the virulence of Leishmania tropica major strains].

Authors:  O I Kellina
Journal:  Med Parazitol (Mosk)       Date:  1965 May-Jun

Review 5.  Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis.

Authors:  D Sacks; S Kamhawi
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

6.  Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection.

Authors:  G F Mitchell; E Handman; T W Spithill
Journal:  Aust J Exp Biol Med Sci       Date:  1984-04

7.  Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites.

Authors:  Wendy van der Meide; Jorge Guerra; Gerard Schoone; Marit Farenhorst; Leíla Coelho; William Faber; Inge Peekel; Henk Schallig
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

8.  Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.

Authors:  D J Bradley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

9.  Late metastatic Leishmaniasis in the mouse. A model for mucocutaneous disease.

Authors:  A Barral; E A Petersen; D L Sacks; F A Neva
Journal:  Am J Trop Med Hyg       Date:  1983-03       Impact factor: 2.345

10.  Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.

Authors:  G S Nabors; J P Farrell
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  37 in total

1.  KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.

Authors:  Yasuyuki Goto; Ajay Bhatia; Vanitha S Raman; Hong Liang; Raodoh Mohamath; Alessandro F Picone; Silvia E Z Vidal; Thomas S Vedvick; Randall F Howard; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2011-06-01

2.  Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200.

Authors:  Mauro Cortez; Chau Huynh; Maria Cecilia Fernandes; Kathleen A Kennedy; Alan Aderem; Norma W Andrews
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

3.  Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites.

Authors:  Dulcilene M Oliveira; Mariana Amália F Costa; Miguel A Chavez-Fumagalli; Diogo G Valadares; Mariana C Duarte; Lourena E Costa; Vivian T Martins; Rosângela F Gomes; Maria N Melo; Manuel Soto; Carlos Alberto P Tavares; Eduardo Antonio F Coelho
Journal:  Parasitol Res       Date:  2011-09-14       Impact factor: 2.289

Review 4.  Vaccines to combat the neglected tropical diseases.

Authors:  Jeffrey M Bethony; Rhea N Cole; Xiaoti Guo; Shaden Kamhawi; Marshall W Lightowlers; Alex Loukas; William Petri; Steven Reed; Jesus G Valenzuela; Peter J Hotez
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis.

Authors:  Neetu Singh; Rajiv Kumar; Shashi Bhushan Chauhan; Christian Engwerda; Shyam Sundar
Journal:  J Infect Dis       Date:  2018-08-24       Impact factor: 5.226

Review 6.  The development and clinical evaluation of second-generation leishmaniasis vaccines.

Authors:  Malcolm S Duthie; Vanitha S Raman; Franco M Piazza; Steven G Reed
Journal:  Vaccine       Date:  2011-11-12       Impact factor: 3.641

7.  TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection.

Authors:  Ismael P Sauter; Katerine G Madrid; Josiane B de Assis; Anderson Sá-Nunes; Ana C Torrecilhas; Daniela I Staquicini; Renata Pasqualini; Wadih Arap; Mauro Cortez
Journal:  JCI Insight       Date:  2019-05-16

8.  Deficiency of lymph node-resident dendritic cells (DCs) and dysregulation of DC chemoattractants in a malnourished mouse model of Leishmania donovani infection.

Authors:  Marwa K Ibrahim; Jeffrey L Barnes; E Yaneth Osorio; Gregory M Anstead; Fabio Jimenez; John J Osterholzer; Bruno L Travi; Seema S Ahuja; A Clinton White; Peter C Melby
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

9.  Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction.

Authors:  Michelle A Favila; Nicholas S Geraci; Erliang Zeng; Brent Harker; David Condon; Rachel N Cotton; Asha Jayakumar; Vinita Tripathi; Mary Ann McDowell
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

10.  Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites.

Authors:  Amrita Sarkar; Yousuf A Khan; Maria Fernanda Laranjeira-Silva; Norma W Andrews; Bidyottam Mittra
Journal:  J Vis Exp       Date:  2018-03-16       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.